{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:53:18Z","timestamp":1776433998532,"version":"3.51.2"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objective<\/jats:title>\n<jats:p>Investigate the role of the Neurogenic locus notch homolog protein 1 (NOTCH1) signaling pathway in Diffuse large B-cell lymphoma (DLBCL)-related heart pathogenesis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Utilize R (version 4.2.1) to retrieve DLBCL and myocardial infarction datasets from the GEO database, normalize data with limma, perform differential analysis and GO analysis with GOplot, and visualize findings with ggplot2. Various assays were conducted including stable cell line construction, myocardial infarction modeling, imaging, Western Blot, ELISA, staining, and functional assays.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Significant gene expression and pathway disparities were found between DLBCL and myocardial infarction samples. NOTCH1, The molecules named Recosomal-binding protein 70 (RBP-J), zeste 2 polycomb repressive complex 2 subunit (EZH2), trimethylated histone H3 at lysine 27 (H3K27me3), Signal Transducer And Activator Of Transcription 3 (STAT3) and Jumonji domain containing-3 (JMJD3) matters a lot in DLBCL. NOTCH1 inhibition decreased DLBCL cell proliferation and activity, reduced inflammatory factors, and improved myocardial fibrosis and infarction severity. NOTCH1 inhibits Granulocyte-macrophage colony-stimulating factor (GM-CSF) and Interleukin-6 (IL-6) expressions depending on STAT3 and EZH2. Co-culturing with DLBCL cells increased fibroblast proliferation, invasion, and fibrosis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>NOTCH1 signaling influences DLBCL development and myocardial infarction severity through the EZH2\/STAT3 pathway, leading to increased heart fibrosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0316923","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:23:14Z","timestamp":1739557394000},"page":"e0316923","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["NOTCH1 promotes the elevation of GM-CSF and IL-6 through the EZH2\/STAT3 pathway to facilitate the fibrotic state of the myocardium in DLBCL"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7867-5997","authenticated-orcid":true,"given":"Huimin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanyi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuexian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingchi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"3","key":"pone.0316923.ref001","first-page":"714","article-title":"[Expressions and Clinical Significance of Notch1 and Hes1 in Diffuse Large B-Cell Lymphoma].","volume":"31","author":"Y Liu","year":"2023","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"1","key":"pone.0316923.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.23038","article-title":"Analysis of Notch1 protein expression in methotrexate-associated lymphoproliferative disorders.","volume":"64","author":"T Okatani","year":"2024","journal-title":"J CLIN EXP HEMATOP"},{"key":"pone.0316923.ref003","first-page":"1","article-title":"Chidamide enhances T-cell-mediated anti-tumor immune function by inhibiting the NOTCH1\/NFATC1 signaling pathway in ABC-type diffuse large B-cell lymphoma","author":"L Li","year":"2024","journal-title":"LEUKEMIA LYMPHOMA"},{"issue":"5","key":"pone.0316923.ref004","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1002\/mco2.346","article-title":"Cellular senescence primes liver fibrosis regression through Notch-EZH2.","volume":"4","author":"P Song","year":"2023","journal-title":"MedComm (2020)."},{"issue":"1","key":"pone.0316923.ref005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chembiol.2019.11.004","article-title":"EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex","volume":"27","author":"JH Hsu","year":"2019","journal-title":"Cell Chem Biol"},{"issue":"8","key":"pone.0316923.ref006","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/carcin\/bgs165","article-title":"Activation of the Notch1\/STAT3\/Twist signaling axis promotes gastric cancer progression","volume":"33","author":"KW Hsu","year":"2012","journal-title":"CARCINOGENESIS"},{"issue":"3","key":"pone.0316923.ref007","first-page":"671","article-title":"Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma","volume":"23","author":"F Gu","year":"2010","journal-title":"ONCOL REP"},{"issue":"3","key":"pone.0316923.ref008","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3892\/ijo.2014.2809","article-title":"Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role","volume":"46","author":"X Zhang","year":"2014","journal-title":"INT J ONCOL"},{"key":"pone.0316923.ref009","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.humpath.2018.08.025","article-title":"Aberrant differential expression of EZH2 and H3K27me3 in extranodal NK\/T-cell lymphoma, nasal type, is associated with disease progression and prognosis.","volume":"83","author":"J Liu","year":"2018","journal-title":"HUM PATHOL."},{"issue":"12","key":"pone.0316923.ref010","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1080\/14728222.2023.2293750","article-title":"miR-26a-5p restoration via EZH2 silencing blocks the IL-6\/STAT3 axis to repress the growth of prostate cancer","volume":"27","author":"W Zhang","year":"2023","journal-title":"EXPERT OPINION THER TAR"},{"issue":"2","key":"pone.0316923.ref011","doi-asserted-by":"crossref","first-page":"e2202937","DOI":"10.1002\/advs.202202937","article-title":"Tumor Cell-Intrinsic SETD2 Deficiency Reprograms Neutrophils to Foster Immune Escape in Pancreatic Tumorigenesis.","volume":"10","author":"N Niu","year":"2022","journal-title":"Adv Sci (Weinh)."},{"issue":"10","key":"pone.0316923.ref012","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20151853","article-title":"GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease","volume":"213","author":"AT Stock","year":"2016","journal-title":"J EXP MED"},{"issue":"4","key":"pone.0316923.ref013","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.bbamcr.2012.10.008","article-title":"GM-CSF promotes inflammatory dendritic cell formation but does not contribute to disease progression in experimental autoimmune myocarditis","volume":"1833","author":"P Blyszczuk","year":"2012","journal-title":"BIOCHIM BIOPHYS ACTA"},{"issue":"3","key":"pone.0316923.ref014","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3109\/10428194.2014.921914","article-title":"The effects of cardiovascular disease on the clinical outcome of elderly patients with diffuse large B-cell lymphoma","volume":"56","author":"HT Tsai","year":"2014","journal-title":"LEUKEMIA LYMPHOMA"},{"issue":"5","key":"pone.0316923.ref015","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/0284186X.2013.844853","article-title":"A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.","volume":"53","author":"A Kinch","year":"2013","journal-title":"ACTA ONCOL."},{"issue":"10","key":"pone.0316923.ref016","first-page":"875","article-title":"[Cardiac Diffuse Large B-Cell Lymphoma Presenting with Acute Heart Failure Due to Cardiac Tamponade].","volume":"44","author":"K Sato","year":"2017","journal-title":"Gan To Kagaku Ryoho."},{"issue":"20","key":"pone.0316923.ref017","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1182\/bloodadvances.2020002737","article-title":"Doxorubicin and subsequent risk of cardiovascular diseases among survivors of diffuse large B-cell lymphoma in Hong Kong.","volume":"4","author":"SF Lee","year":"2020","journal-title":"BLOOD ADV"},{"issue":"16_suppl","key":"pone.0316923.ref018","doi-asserted-by":"crossref","first-page":"7541","DOI":"10.1200\/JCO.2022.40.16_suppl.7541","article-title":"Preclinical activity of irreversible Menin inhibitor, BMF-219, in chronic lymphocytic leukemia","volume":"40","author":"P Somanath","year":"2022","journal-title":"J CLIN ONCOL"},{"issue":"15_suppl","key":"pone.0316923.ref019","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1200\/JCO.2020.38.15_suppl.8004","article-title":"A multicenter phase II study of venetoclax plus dose-adjusted R-EPOCH (VR-EPOCH) for Richter\u2019s syndrome.","volume":"38","author":"MS Davids","year":"2020","journal-title":"J CLIN ONCOL."},{"issue":"1","key":"pone.0316923.ref020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41392-023-01358-y","article-title":"Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.","volume":"8","author":"R Shen","year":"2023","journal-title":"SIGNAL TRANSDUCT TAR"},{"issue":"12","key":"pone.0316923.ref021","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.ccell.2021.10.006","article-title":"Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL","volume":"39","author":"WH Wilson","year":"2021","journal-title":"CANCER CELL"},{"issue":"Supple 1","key":"pone.0316923.ref022","first-page":"1550","article-title":"Venetoclax, Obinutuzumab, and atezolizumab (PD-L1 Checkpoint Inhibitor) for Treatment for Patients with Richter Transformation BLOOD.","volume":"138","author":"N Jain","year":"2021"},{"issue":"Supple 1","key":"pone.0316923.ref023","first-page":"18","article-title":"The Genetic Landscape in Elderly DLBCL Aged &gt; 75 Years in the Australasian Leukaemia & Lymphoma Group NHL29 Iric Trial Identifies New Targetable Mutations BLOOD","volume":"136","author":"S Rijal","year":"2020"},{"issue":"Supple 1","key":"pone.0316923.ref024","first-page":"29","article-title":"Characterizing Specificities of Chronic Lymphoid Leukemia Harboring a BCL2 rearrangement BLOOD.","volume":"136","author":"C Herbaux","year":"2020"},{"issue":"1","key":"pone.0316923.ref025","first-page":"27","article-title":"Morphoproteomics Identifies SIRT1, EZH2 and CXCR4 Pathways in Diffuse Large B-Cell Lymphoma: Therapeutic Implications.","volume":"52","author":"RE Brown","year":"2022","journal-title":"ANN CLIN LAB SCI."},{"issue":"Supple 1","key":"pone.0316923.ref026","first-page":"2410","article-title":"Amengual","volume":"138","author":"E Ricker","year":"2021","journal-title":"Dual Targeting of EZH2 and HDAC with Tazemetostat and Belinostat Promotes Immunogenicity in GC-DLBCL BLOOD."},{"issue":"17","key":"pone.0316923.ref027","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174249","article-title":"The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma.","volume":"13","author":"X Wang","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"4","key":"pone.0316923.ref028","doi-asserted-by":"crossref","first-page":"e0174775","DOI":"10.1371\/journal.pone.0174775","article-title":"Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3.","volume":"12","author":"MM Sherry-Lynes","year":"2017","journal-title":"PLoS One."},{"issue":"11","key":"pone.0316923.ref029","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41423-022-00919-5","article-title":"Macrophage-specific inhibition of the histone demethylase JMJD3 decreases STING and pathologic inflammation in diabetic wound repair","volume":"19","author":"CO Audu","year":"2022","journal-title":"CELL MOL IMMUNOL"},{"issue":"6","key":"pone.0316923.ref030","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ejheart.2005.12.007","article-title":"Granulocyte Macrophage-Colony Stimulating Factor receptor expression on human cardiomyocytes from end-stage heart failure patients","volume":"8","author":"L Postiglione","year":"2006","journal-title":"EUR J HEART FAIL"},{"issue":"2","key":"pone.0316923.ref031","first-page":"139","article-title":"Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction","volume":"15","author":"JT Parissis","year":"2004","journal-title":"Eur Cytokine Netw"},{"issue":"46","key":"pone.0316923.ref032","doi-asserted-by":"crossref","first-page":"69635","DOI":"10.1007\/s11356-022-20441-5","article-title":"Ameliorative effect of flavonoids on cyclophosphamide-induced cardio and neurotoxicity via targeting the GM-CSF\/NF-\u03baB signaling pathway.","volume":"29","author":"FF Elsayed","year":"2022","journal-title":"ENVIRON SCI POLLUT R"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0316923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:23:31Z","timestamp":1739557411000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0316923"}},"subtitle":[],"editor":[{"given":"Meijing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0316923","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}